| Dr Shanti J Seker, MD | |
|
6320 159th St, Suite A, Oak Forest, IL 60452-2776 | |
| (708) 687-3855 | |
| (708) 444-2324 |
| Full Name | Dr Shanti J Seker |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology - Allergy |
| Location | 6320 159th St, Oak Forest, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437237476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 036-045260 (Illinois) | Primary |
| Entity Name | Mount Sinai Community Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376715896 PECOS PAC ID: 5991600405 Enrollment ID: O20040202001032 |
News Archive
New tests to detect early Lyme disease – which is increasing beyond the summer months – could replace existing tests that often do not clearly identify the infection before health problems occur.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
Researchers have developed wearable wireless monitors that contain stretchable electronics and would provide long term health data about the adults, babies and children. These sensors are an advantage over the presently used devices because they are free from the risk of skin allergic reactions and injuries that are associated with conventional adhesive sensors containing conductive gel formulations.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 6 days ago
| Entity Name | Foundation For Outreach Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316350242 PECOS PAC ID: 3375507163 Enrollment ID: O20041111001020 |
News Archive
New tests to detect early Lyme disease – which is increasing beyond the summer months – could replace existing tests that often do not clearly identify the infection before health problems occur.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
Researchers have developed wearable wireless monitors that contain stretchable electronics and would provide long term health data about the adults, babies and children. These sensors are an advantage over the presently used devices because they are free from the risk of skin allergic reactions and injuries that are associated with conventional adhesive sensors containing conductive gel formulations.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shanti J Seker, MD 6320 159th St, Suite A, Oak Forest, IL 60452-2776 Ph: (708) 687-3855 | Dr Shanti J Seker, MD 6320 159th St, Suite A, Oak Forest, IL 60452-2776 Ph: (708) 687-3855 |
News Archive
New tests to detect early Lyme disease – which is increasing beyond the summer months – could replace existing tests that often do not clearly identify the infection before health problems occur.
Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.
Researchers have developed wearable wireless monitors that contain stretchable electronics and would provide long term health data about the adults, babies and children. These sensors are an advantage over the presently used devices because they are free from the risk of skin allergic reactions and injuries that are associated with conventional adhesive sensors containing conductive gel formulations.
By deciphering the ingenious mechanism used by a particular enzyme to modify bacterial chromosome chemistry, scientists have come a step closer to designing a new kind of drug that could stop virulent bacterial infections in their tracks. Their research will be published in the May 6 issue of the journal Cell.
› Verified 6 days ago
Dr. Nirmala M Ray, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 6320 159th St, Suite A, Oak Forest, IL 60452 Phone: 708-687-3855 Fax: 708-444-2324 | |
Dr. Pisit Rangsithienchai, M.D. Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 5601 Victoria Dr, Oak Forest, IL 60452 Phone: 708-687-7550 Fax: 708-687-7552 |